2019
DOI: 10.1080/14712598.2019.1607836
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal stromal cells for ocular surface repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 87 publications
0
7
0
Order By: Relevance
“…Thus, the co-cultivation of LEPC with LMSC/LM could represent an improved strategy to generate cell transplants for patients suffering from limbal stem cell deficiency [ 10 , 11 ]. In addition, both LMSC and LM were shown to have potent immunomodulatory, anti-inflammatory and anti-angiogenic properties, making them attractive tools for clinical use [ 9 , 12 , 13 , 14 ]. To date, research on freshly isolated LMSC or LM, which may closely resemble the LNC in vivo, has been hampered by the lack of an efficient and fast protocol for isolating these cells as pure populations.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the co-cultivation of LEPC with LMSC/LM could represent an improved strategy to generate cell transplants for patients suffering from limbal stem cell deficiency [ 10 , 11 ]. In addition, both LMSC and LM were shown to have potent immunomodulatory, anti-inflammatory and anti-angiogenic properties, making them attractive tools for clinical use [ 9 , 12 , 13 , 14 ]. To date, research on freshly isolated LMSC or LM, which may closely resemble the LNC in vivo, has been hampered by the lack of an efficient and fast protocol for isolating these cells as pure populations.…”
Section: Introductionmentioning
confidence: 99%
“…Current treatments often include corneal transplantation if the visual axis is affected, which has limitations due to donor availability and compatibility. To restore corneal transparency and integrity, Ad-MSCs therapy has been investigated [ 35 , 36 , 37 , 38 , 39 ]. Using clinical and animal studies, Ad-MSCs therapy has recently proven to be a promising method used in corneal reconstruction with multiple treatment approaches [ 40 , 41 , 42 , 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Over the last few years, the field of cell-based therapies to treat both DED and LSCD pathologies has undergone great development. Experimental and clinical MSC-based therapies have increased in the last decade due to their immunomodulatory and anti-inflammatory properties, their capability to migrate to injured and inflamed tissues, and their capacity to differentiate into corneal epithelial cells [ 82 ].…”
Section: Corneal Epithelium Adsc Regeneration: Preclinical and Clinic...mentioning
confidence: 99%